RBC Capital: 'Amgen (AMGN) Highlights Key Growth Drivers For The Rest Of 2026 And Beyond'
Tweet Send to a Friend
RBC Capital analyst Luca Issi reiterated an Outperform rating and $360.00 price target on Amgen (NASDAQ: AMGN).The analyst commented: "AMGN ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
